These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39174572)

  • 41. Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety.
    Gao W; Walther A; Wekenborg M; Penz M; Kirschbaum C
    Talanta; 2020 Sep; 217():121006. PubMed ID: 32498885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of the endocannabinoid anandamide, related N-acylethanolamines and linoleic acid-derived oxylipins in patients with migraine.
    Gouveia-Figueira S; Goldin K; Hashemian SA; Lindberg A; Persson M; Nording ML; Laurell K; Fowler CJ
    Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():15-24. PubMed ID: 28515018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and
    Ferrara AL; Piscitelli F; Petraroli A; Parente R; Galdiero MR; Varricchi G; Marone G; Triggiani M; Di Marzo V; Loffredo S
    J Immunol Res; 2019; 2019():5836476. PubMed ID: 31355297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.
    Petrosino S; Schiano Moriello A; Cerrato S; Fusco M; Puigdemont A; De Petrocellis L; Di Marzo V
    Br J Pharmacol; 2016 Apr; 173(7):1154-62. PubMed ID: 25598150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.
    Zelber-Sagi S; Azar S; Nemirovski A; Webb M; Halpern Z; Shibolet O; Tam J
    Obesity (Silver Spring); 2017 Jan; 25(1):94-101. PubMed ID: 27863097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma endocannabinoid levels in multiple sclerosis.
    Jean-Gilles L; Feng S; Tench CR; Chapman V; Kendall DA; Barrett DA; Constantinescu CS
    J Neurol Sci; 2009 Dec; 287(1-2):212-5. PubMed ID: 19695579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
    van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
    Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
    Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
    BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of 2-Arachidonoylglycerol by μSPE-LC-MS/MS.
    Battista N; Sergi M
    Methods Mol Biol; 2016; 1412():19-26. PubMed ID: 27245888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.
    Zoerner AA; Gutzki FM; Suchy MT; Beckmann B; Engeli S; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2909-23. PubMed ID: 19414283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating endocannabinoid concentrations in grieving adults.
    Harfmann EJ; McAuliffe TL; Larson ER; Claesges SA; Sauber G; Hillard CJ; Goveas JS
    Psychoneuroendocrinology; 2020 Oct; 120():104801. PubMed ID: 32682172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice.
    Gong Y; Li X; Kang L; Xie Y; Rong Z; Wang H; Qi H; Chen H
    J Pharm Biomed Anal; 2015; 111():57-63. PubMed ID: 25863017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis.
    Carter GT; McLaughlin RJ; Cuttler C; Sauber GJ; Weeks DL; Hillard CJ; Weiss MD
    Muscle Nerve; 2021 Jan; 63(1):120-126. PubMed ID: 33094490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry.
    Acquaro Junior VR; Goméz-Ríos GA; Tascon M; Costa Queiroz ME; Pawliszyn J
    Anal Chim Acta; 2019 Dec; 1091():135-145. PubMed ID: 31679567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.
    Fuentes JJ; Mayans J; Guarro M; Canosa I; Mestre-Pintó JI; Fonseca F; Torrens M
    BMC Psychiatry; 2024 Aug; 24(1):551. PubMed ID: 39118031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies.
    Sharma K; Singh RR; Kandaswamy M; Mithra C; Giri S; Rajagopal S; Mullangi R
    Bioanalysis; 2011 Jan; 3(2):181-96. PubMed ID: 21250847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells.
    Matias I; Gonthier MP; Petrosino S; Docimo L; Capasso R; Hoareau L; Monteleone P; Roche R; Izzo AA; Di Marzo V
    Br J Pharmacol; 2007 Nov; 152(5):676-90. PubMed ID: 17704823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.
    Yi B; Nichiporuk I; Nicolas M; Schneider S; Feuerecker M; Vassilieva G; Thieme D; Schelling G; Choukèr A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():92-7. PubMed ID: 26780604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.